Journal
/
/
Differentiation of Atrial Cardiomyocytes from Pluripotent Stem Cells Using the BMP Antagonist Grem2
JoVE Journal
Developmental Biology
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Developmental Biology
Differentiation of Atrial Cardiomyocytes from Pluripotent Stem Cells Using the BMP Antagonist Grem2
DOI:

08:52 min

March 10, 2016

,

Chapters

  • 00:05Title
  • 00:33Murine Embryonic Stem Cell (mESC) Culture and Passaging
  • 03:16Embryoid Body (EB) Preparation and Grem2 Treatment
  • 06:12Results: Grem2-induction of Cardiomyocyte Differentiation
  • 08:00Conclusion

Summary

Automatic Translation

Generating cardiomyocytes from pluripotent stem cells in vitro allows access to large amounts of cardiac tissue in vitro for basic science and clinical applications. This protocol uses the atrializing factor Grem2 to both increase the numbers of cardiomyocytes obtained and to generate cardiomyocytes with an atrial phenotype.

Related Videos

Read Article